Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)

被引：0

作者：

Pfeifer, Heike ^{[1
]}

Goekbuget, Nicola ^{[2
]}

Voelp, Christian ^{[1
]}

Huettmann, Andreas ^{[3
]}

Luebbert, Michael ^{[4
]}

Stuhlmann, Reingard ^{[5
]}

Dengler, Julanta ^{[6
]}

Kreuzer, Karl-Anton ^{[7
]}

Beck, Joachim ^{[8
]}

Stelljes, Matthias ^{[9
]}

Schmid, Mathias ^{[10
]}

Wassmann, B. ^{[1
]}

Leimer, Lothar ^{[11
]}

Spiekermann, Karsten ^{[12
]}

Terwey, Theis E. ^{[13
]}

Schaefer-Eckart, K. ^{[14
]}

Ditz, D. ^{[15
]}

Lindemann, H. ^{[16
]}

Morgner, A. ^{[17
]}

Schaich, Markus ^{[18
]}

Burmeister, Thomas ^{[19
]}

Binckebanck, A. ^{[1
]}

Hoelzer, Dieter

Ottmann, Oliver G. ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany

[2] Goethe Univ Hosp, Dept Med, Frankfurt, Germany

[3] Univ Hosp, D-45122 Essen, Germany

[4] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany

[5] Asklepios Klin St Georg, Hamburg, Germany

[6] Univ Heidelberg, Dept Hematol, Heidelberg, Germany

[7] Univ Cologne, Dept Internal Med 1, Cologne, Germany

[8] Univ Hosp, Mainz, Germany

[9] Univ Munster, Munster, Germany

[10] Univ Hosp Ulm, Ulm, Germany

[11] Robert Bosch Krankenhaus, Stuttgart, Germany

[12] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany

[13] Charite, D-13353 Berlin, Germany

[14] Klinikum Nurnberg, Dept Hematol, Med Klin 5, Nurnberg, Germany

[15] Univ Regensburg, Regensburg, Germany

[16] Katholisches Krankenhaus Hagen, Dresden, Germany

[17] Krankenhaus Kuchwald Chemnitz, Dresden, Germany

[18] Univ Klinikum Carl Gustav Carus, Dresden, Germany

[19] Univ Hosp Berlin, Charlie, Dept Hematol & Oncol, Berlin, Germany

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：79 / 79

页数：1

共 50 条

[1] Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Wassmann, Barbara
Pfeifer, Heike
Goekbuget, Nicola
Beelen, Dietrich W.
Beck, Joachim
Stelljes, Matthias
Bornhaeuser, Martin
Reichle, Albrecht
Perz, Jolanta
Haas, Rainer
Ganser, Arnold
Schmid, Mathias
Kanz, Lothar
Lenz, Georg
Kaufmann, Martin
Binckebanck, Anja
Brueck, Patrick
Reutzel, Regina
Gschaidmeier, Harald
Schwartz, Stefan
Hoelzer, Dieter
Ottmann, Oliver G.
BLOOD, 2006, 108 (05) : 1469 - 1477
[2] THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA
Delannoy, A.
Delabesse, E.
Lheritier, V.
Castaigne, S.
Rigal-Huguet, F.
Raffoux, E.
Garban, F.
Legrand, O.
Bologna, S.
Dubruille, V.
Turlure, P.
Reman, O.
Delain, M.
Isnard, F.
Coso, D.
Raby, P.
Buzyn, A.
Cailleres, S.
Darre, S.
Fohrer, C.
Sonet, A.
Bilhou-Nabera, C.
Bene, M. -C.
Dombret, H.
Thomas, X.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 30 - 31
[3] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Ottmann, Oliver G.
Wassmann, Barbara
Pfeifer, Heike
Giagounidis, Aristoteles
Stelljes, Matthias
Duehrsen, Ulrich
Schmalzing, Marc
Wunderle, Lydia
Binckebanck, Anja
Hoelzer, Dieter
CANCER, 2007, 109 (10) : 2068 - 2076
[4] Short Chemotherapy-Phased Imatinib (IM) Pulses Improve Long-Term Outcome of Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
Bassan, Renato
Rossi, Giuseppe
Pogliani, Enrico Maria
Di Bona, Eros
Angelucci, Emanuele
Cavattoni, Irene
Cortelezzi, Agostino
Gianfaldoni, Giacomo
Levis, Alessandro
Ciceri, Fabio
Mattei, Daniele
Borlenghi, Erika
Terruzzi, Elisabetta
Borghero, Carlo
Romani, Claudio
Spinelli, Orietta
Tosi, Manuela
Oldani, Elena
Intermesoli, Tamara
Rambaldi, Alessandro
BLOOD, 2009, 114 (22) : 801 - 801
[5] LONG-TERM OUTCOME OF RELAPSED ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CONTINUOUS IMATINIB PLUS COMBINATION CHEMOTHERAPY
Lim, S.
Joo, Y. D.
Lee, J. H.
Lee, J. H.
Kim, D. Y.
Sohn, B. S.
Lee, K. H.
Kim, I. H.
HAEMATOLOGICA, 2016, 101 : 357 - 357
[6] Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia
Guillet, Stephanie
Hirsch, Pierre
Marzac, Christophe
Mohty, Mohamad
Marie, Jean-Pierre
Legrand, Ollivier
LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2646 - 2648
[7] Imatinib given concurrently with induction chemotherapy is superior to imatinib subsequent to induction and consolidation in newly diagnosed Philadelphia-positive acute lymphoblastic leukemia (PH plus ALL).
Ottmann, OG
Wassmann, B
Pfeifer, H
Goekbuget, N
Bug, G
Brueck, P
Binckebanck, A
Gschaidmeier, H
Hoelzer, D
BLOOD, 2004, 104 (11) : 197A - 197A
[8] Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate
Ribera, JM
Oriol, A
Gonzalez, M
Vidriales, MB
Xicoy, B
Grau, J
Esteve, J
Brunet, S
Del Potro, E
Moreno, MJ
Tormo, M
Martin-Reina, MV
Deben, G
Parody, R
Lahuerta, UJ
San Miguel, JF
BLOOD, 2004, 104 (11) : 203B - 204B
[9] Treatment of Philadelphia-positive acute lymphocytic leukemia (Ph plus ALL) in the elderly with imatinib mesylate (ST1571) and chemotherapy.
Delannoy, A
Lhéritier, V
Thomas, X
Castaigne, S
Rigal-Huguet, F
Raffoux, E
Garban, F
Legrand, O
Witz, F
Dubruille, V
Turlure, P
Troussard, X
Delain, M
Isnard, F
Coso, D
Raby, P
Buzyn, A
Caillères, S
Darre, S
Lioure, B
Sonet, A
Bilhou-Nabera, C
Bene, MC
Macintyre, E
Delabesse, E
Vernant, JP
Ifrah, N
Dombret, H
Berthaud, P
Fière, D
BLOOD, 2005, 106 (11) : 46A - 46A
[10] Long-lasting response in patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) treated with imatinib mesylate (Glivec, STI-571)
Martinez, J
de la Rubia, J
Martin, G
Sanz, G
Cervera, J
Pérez-Sirvent, M
Lorente, P
Linares, D
Jarque, I
Lorenzo, I
Sanz, M
BONE MARROW TRANSPLANTATION, 2003, 31 : S179 - S180

← 1 2 3 4 5 →